Skip to main content

Table 1 Significantly (p<0.0001) different mass peaks between benign and malignant cyst fluid samples, with ROC AUC >0.70 are listed with m/z value and identified peaks

From: Ovarian cyst fluid is a rich proteome resource for detection of new tumor biomarkers

Protein

Fraction

Peak m/z value

Mean intensity benign/malignant

ROC AUC

Specificity % (CI)

PCI

EB-E3

3902

30.23 / 7.00

0.79

67.7 (58.9-75.6)

ApoC-III

EB-E3

9743

3.60 / 15.09

0.82

68.5 (59.7-76.3)

ApoC-III

EB-E3

9448

5.29 / 22.00

0.80

60.8 (51.8-69.2)

ApoC-III

EB-E2

9751

4.65 / 24.2

0.80

60.8 (51.8-69.2)

ApoC-III

EB-E2

9777.5

3.20 / 14.7

0.79

63.1 (54.2-71.4)

ApoC-III

EB-E3

9453

7.30 / 33.20

0.78

50 (41.1-58.9)

ApoC-I

MEP-M1

6647

37.53 / 121.14

0.78

57.7 (48.7-66.3)

ApoC-I - truncated

MEP-M1

6448

68.91 / 184.53

0.76

53.1 (44.1-61.9)

ApoC-I - truncated

MEP-M1

6489

24.49 / 52.75

0.76

53.1 (44.1-61.9)

SAA4

MEP-M1

12886

1.35 / 2.42

0.76

58.5 (49.5-67.0)

SAA4

MEP-M1

12863

1.53 / 2.72

0.74

59.2 (50.3-67.8)

TTR

EB-E3

13900

7.80 / 23.16

0.77

59.2 (50.3-67.8)

TTR

EB-E3

13925

5.36 / 14.27

0.75

57.7 (48.7-66.3)

Hb beta

FT

8037

2.61 / 4.64

0.75

65.4 (56.5-73.5)

Albumin

FT

54622

0.73 / 0.30

0.76

61.5 (52.6-69.9)

Albumin

FT

54426

1.72 / 0.25

0.75

60.8 (51.8-69.2)

Albumin ion

MEP-M1

44754

1.06 / 0.50

0.76

57.7 (48.7-66.3)

  1. PCI = protein C inhibitor, ApoC-III = apolipoprotein C-III, ApoC-I = apolipoprotein C-I, SAA4 = serum amyloid A4, and TTR = transthyretin, EB = Equalizer Beads, differentially eluted yield fractions E2, and E3, MEP = Mercapto ethyl pyridine beads, differentially eluted yield fractions M1.